Today Maryland Congressman Chris Van Hollen issued the following statement on President Obama's signing into law the Food and Drug Administration Safety and Innovation Act, which incorporates the Creating Hope Act of 2011 and will encourage the development of new drugs to treat rare pediatric diseases such as childhood cancer:
"As co-chair of the Childhood Cancer Caucus, I have heard too many stories of children and families whose lives have been devastated by childhood cancer. I'm very pleased that the bill being signed by the President today will lead to better, safer treatments for these young people. By incentivizing pharmaceutical companies to invest in developing new drugs for rare pediatric diseases, we are bringing much needed help and hope to thousands of American children and families affected by childhood cancer."